Avicanna
Advantage
Disrupting the Cannabinoid
Industry with Science
A Leader in Biopharmaceutical Advancements with Natural Cannabinoids
Avicanna is a Canadian vertically-integrated biopharmaceutical company focused on evidence-based utility of cannabinoids.
Recently Commercialized with diversified and high margin income streams
- Comprehensive commercial portfolio – consumer retail, medical cannabis and pharmaceutical
- International footprint – multinational operations and sales across US, Canada, LATAM and Europe
- Partnership with Shoppers Drug Mart – RHO Phyto medical cannabis products nation-wide in Canada
Trusted scientific platform, including R&D, pre-clinical and clinical infrastructure
- Cannabinoid R&D expertise – Team of 10+ scientists operating with Canadian Cannabis Research Licenses
- World-Class collaborations – with leading Canadian academic and clinical institutions for 3 + years
- Established Intellectual property portfolio – 3+ years of IP development and optimization
Established and Proven low-cost vertical integration
- 2 Colombian subsidiaries – cultivation footprint of 480,000 sq feet with industrial extraction capacity
- Organic and sustainable cultivation – ranked highest amongst global cannabis companies in the SAM Corporate Sustainability Assessment issued by S&P Global
Hemp-derived Consumer Retail Products
Medical Products
Pharmaceutical Pipeline
Active Pharmaceutical Ingredients
Genetics and Seeds
